Arenaemycin (pentalenolactone): a specific inhibitor of glycolysis.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000037:antagonists & inhibitors*; D006019:Glycolysis / Q000187:drug effects*; D007783:Lactones / Q000494:pharmacology; D009132:Muscles / Q000201:enzymology; D011817:Rabbits; D012441:Saccharomyces cerevisiae / Q000201:enzymology; D012717:Sesquiterpenes
D000900:Anti-Bacterial Agents; D007783:Lactones; D012717:Sesquiterpenes; C017996:arenaemycin E; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D005947:Glucose